Key Takeaways
- • Angelini Ventures achieves first portfolio exit: The Italian venture capital firm sold its stake in U.S.-based Noctrix Health to Australian healthcare company ResMed for $340 million, representing a significant return on its 2024 Series C investment.
- • Bending Spoons closes $200 million funding round: The Italian app developer attracted Durable and other investors in a substantial capital raise, signaling continued investor confidence in the company's growth trajectory.
- • Angelini Ventures' Noctrix investment in 2024 Series C: The VC firm participated in Noctrix Health's $40 million Series C financing round alongside leading healthcare investors, demonstrating strategic healthcare sector exposure.
- • Continued Italian venture capital activity: The roundup captures ongoing deal flow across Italy's startup ecosystem, including activity from established VCs and emerging fund managers across multiple sectors including healthcare, software, and technology infrastructure.
Summary
Concurrently, Bending Spoons, an Italian software developer, is closing a $200 million funding round led by investor Durable, demonstrating sustained capital availability for established Italian tech companies. The round reflects investor appetite for proven software platforms with established market positions and revenue streams.
The broader Italian venture capital landscape continues to show activity across multiple subsectors and fund managers. The weekly roundup captures ongoing deal flow among established players including Angelini Ventures and emerging ecosystem participants, though detailed information on individual deals beyond the headline transactions remains limited in the current reporting. These transactions reflect the maturation of Italy's venture capital market and the increasing ability of Italian-backed companies to achieve meaningful exits and secure substantial growth capital in competitive funding environments.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.